Sanofi Acquires Qunol

September 29, 2023

Sanofi has completed the acquisition of Qunol, a U.S.-based vitamins and supplements brand, to strengthen its Consumer Healthcare (CHC) portfolio in the Vitamin, Mineral and Supplements (VMS) category. The deal adds Qunol's CoQ10 and Turmeric offerings—targeting heart and joint health—to Sanofi's U.S. consumer health lineup and supports expansion into the healthy-aging segment.

Buyers
Sanofi
Targets
Qunol
Location
New Jersey, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.